Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
News & Events
Apr 29, 2025 12:00:00 AM / by Orchestra BioMed posted in Regulatory
Apr 22, 2025 12:15:00 AM / by Orchestra BioMed posted in Regulatory
Feb 18, 2025 12:15:00 AM / by Orchestra BioMed posted in Corporate
© 2025 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01